Latest AI and machine learning research in metabolic syndrome for healthcare professionals.
Carotid plaque presence is associated with cardiovascular risk, even among asymptomatic individuals. While deep learning has shown promise for carotid plaque phenotyping in patients with advanced atherosclerosis, its application in population-based settings of asymptomatic individuals remains unexplored. We developed a YOLOv8-based model for plaque detection using carotid ultrasound images from 19...
Monitoring the effectiveness of statin therapy in patients with dyslipidemia is essential for ensuring optimal treatment outcomes. The current standard involves lipid profiling via blood tests to detect abnormalities in blood lipids. This study evaluated the feasibility of a non-invasive, breath-based approach to statin therapy monitoring using Noze’s electronic nose (eNose) platform. A total of 3...
Hypertension is a major modifiable risk factor for cardiovascular diseases. Early identification of high-risk individuals using predictive models can ...
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined multisystem disease continuum characterized by the coexistence of metabolic dysfunct...
Diabetes, hypertension, and dyslipidemia are major risk factors for cardiovascular (CVD), cerebral, and renal diseases (RD). However, the underlying m...
Opioids are a widely prescribed class of medication for pain management. However, they have variable efficacy and adverse effects among patients, due ...
Hypertension (HTN) is a leading, yet often underdiagnosed, cause of cardiovascular diseases worldwide. While clinical risk scores like the Framingham ...
Hypertensive heart disease (HHD) encompasses diverse clinical profiles, comorbidities, and cardiac remodeling, but current classifications insufficien...
Alzheimer’s Disease and Related Dementias (ADRD) affect millions worldwide and can begin over a decade before symptoms appear. ADRD are generally irre...
Patients with diabetes undergoing hemodialysis (HD) are at risk of asymptomatic hypo- and hypergly-cemia within 24 hours of dialysis. Continuous gluco...
Metformin has been increasingly used off-label in adolescents with type 1 diabetes (T1D) or prediabetic conditions to improve glycemic control. Despit...
Pulmonary hypertension (PH) is a highly morbid disease, but underdiagnosis is common outside of expert referral centers. Consequentially, there may be...
Frailty and multimorbidity are common in older adults and contribute substantially to prolonged hospitalizations, readmissions, and mortality. Yet, ex...
Pelvic floor dysfunction (PFD) is a highly prevalent and heterogeneous condition among women. The traditional view of PFD as a single clinical entity ...
Diabetes mellitus (DM) is a major risk factor for acquiring infections. Metformin, the first-line treatment for type 2 DM, is associated with benefici...
Arterial aging, marked by progressive vascular stiffening, is a contributor to cardiovascular disease. Photoplethysmography (PPG) waveforms offer an e...
Dementia poses an escalating global health burden, yet its underlying mechanisms remain incompletely understood. In this large-scale, targeted metabol...
Wearable and cuffless blood pressure (BP) monitoring hold great promise for preventive hypertension management, yet few studies have been validated un...
Standard LDL-C equations were derived in cohorts largely untreated with modern combination diabetes therapies. With medication-treated patients compri...
Diabetes Mellitus (DM) represents one of the most significant global public health challenges of the 21st century. This dramatic increase in the preva...